PWM
TMO icon

Prentice Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Prentice Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-466
Closed -$226K – 117
2025
Q3 		$226K Sell
466
-357
-43% -$166K 0.06% 108
2025
Q2 		$334K Sell
823
-237
-22% -$99.1K 0.09% 96
2025
Q1 		$527K Buy
1,060
+20
+2% +$10.8K 0.15% 76
2024
Q4 		$541K Buy
1,040
+70
+7% +$38.5K 0.16% 74
2024
Q3 		$600K Buy
970
+57
+6% +$33.7K 0.18% 66
2024
Q2 		$505K Buy
913
+19
+2% +$10.9K 0.16% 75
2024
Q1 		$520K Buy
894
+69
+8% +$38.7K 0.18% 76
2023
Q4 		$438K Buy
825
+16
+2% +$7.75K 0.17% 73
2023
Q3 		$409K Buy
809
+9
+1% +$4.8K 0.19% 66
2023
Q2 		$417K Buy
800
+186
+30% +$100K 0.19% 69
2023
Q1 		$354K Buy
614
+32
+5% +$18K 0.17% 74
2022
Q4 		$321K Buy
582
+51
+10% +$27K 0.16% 73
2022
Q3 		$277K Buy
+531
New +$297K 0.15% 71
2022
Q2 		– Sell
-467
Closed -$275K – 181
2022
Q1 		$275K Buy
467
+37
+9% +$21.3K 0.13% 79
2021
Q4 		$286K Sell
430
-9
-2% -$5.62K 0.13% 75
2021
Q3 		$251K Buy
439
+2
+0.5% +$1.1K 0.12% 89
2021
Q2 		$220K Buy
437
+171
+64% +$80.7K 0.11% 99
2021
Q1 		$121K Buy
+266
New +$127K 0.07% 122

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Prentice Wealth Management's TMO Position: Q4 2025 in Review

Prentice Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 466 shares — an estimated $226K sold.

Prentice Wealth Management first reported a position in TMO in Q1 2021 and held it in 18 quarters. The position peaked at $600K in Q3 2024. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Prentice Wealth Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Prentice Wealth Management sold 466 Thermo Fisher Scientific shares in Q4 2025, an estimated $226K.
  • Prentice Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 18 quarters.
  • Prentice Wealth Management's Thermo Fisher Scientific position peaked at $600K in Q3 2024.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Prentice Wealth Management's 13F filing for Q4 2025, filed 30 Jan 2026.